Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Telemed J E Health ; 30(5): 1436-1442, 2024 May.
Article in English | MEDLINE | ID: mdl-38215269

ABSTRACT

Background: Growth of international travel to malarial areas over the last decades has contributed to more travelers taking malaria prophylaxis. Travel-related symptoms may be wrongly attributed to malaria prophylaxis and hinder compliance. Here, we aimed to assess the frequency of real-time reporting of symptoms by travelers following malaria prophylaxis using a smartphone app. Method: Adult international travelers included in this single-center study (Barcelona, Spain) used the smartphone Trip Doctor® app developed by our group for real-time tracking of symptoms and adherence to prophylaxis. Results: Six hundred four (n = 604) international travelers were included in the study; 74.3% (449) used the app daily, and for one-quarter of travelers, malaria prophylaxis was prescribed. Participants from the prophylaxis group traveled more to Africa (86.7% vs. 4.3%; p < 0.01) and to high travel medical risk countries (60.8% vs. 18%; p < 0.01) and reported more immunosuppression (30.8% vs. 23.1% p < 0.01). Regarding symptoms, no significant intergroup differences were observed, and no relationship was found between the total number of malarial pills taken and reported symptoms. Conclusions: In our cohort, the number of symptoms due to malaria prophylaxis was not significantly higher than in participants for whom prophylaxis was not prescribed, and the overall proportion of symptoms is higher compared with other studies.


Subject(s)
Antimalarials , Malaria , Mobile Applications , Smartphone , Humans , Malaria/prevention & control , Female , Male , Antimalarials/adverse effects , Antimalarials/administration & dosage , Antimalarials/therapeutic use , Adult , Middle Aged , Spain , Travel , Medication Adherence/statistics & numerical data , Young Adult
2.
Int J Occup Saf Ergon ; 29(4): 1335-1344, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36217607

ABSTRACT

Objectives. The improvised and massive adoption of remote work in the context of COVID-19 has forced us to adapt homes as workspaces, which could promote development of musculoskeletal disorders (MSDs). This review explores the evidence for ergonomic factors associated with MSDs in teleworkers. Methods. A literature search was conducted in MEDLINE, Embase, Scopus, SciELO and EBSCO. We included observational studies published between March 2020 and October 2021 that included teleworking personnel due to the restrictions of the pandemic. Results. A total of 212 studies were identified, 14 were chosen for complete review. Associated factors were change of work modality (on-site work to telework), use of home environments as workspaces (areas not adapted for work and with low lighting), working furniture (non-ergonomic chairs and desks), use of electronic devices (tablets, cell phones and laptops), organizational factors (working hours, active breaks, sitting time) and individual factors (physical activity practice). Conclusion. Various ergonomic home factors and the characteristics of teleworking - mainly furniture, the environment of work and physical activity - are associated with MSDs. This evidence suggests that the norms and regulation of telework can consider the adaptation of workspace and conditions at home to prevent health problems in the medium and long term.


Subject(s)
COVID-19 , Musculoskeletal Diseases , Occupational Diseases , Humans , Teleworking , Pandemics , Occupational Diseases/epidemiology , Occupational Diseases/prevention & control , COVID-19/epidemiology , Ergonomics/methods , Musculoskeletal Diseases/epidemiology , Musculoskeletal Diseases/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...